Journals / Turkish Journal of Medical Sciences / 2015 / Cilt: 45 - Sayı: 3

Characterization of HCV genotype 4d infections in Kayseri, Turkey*

Pages
547–552
Publication Date
2015-08-13
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: The introduction of type 4d HCV into the Kayseri region probably took place 30-75 years ago, as predicted by molecular clock analysis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: The frequency of genotype 4 hepatitis C virus (HCV) infections is significantly higher in Kayseri compared to other provinces in Turkey.
📊
Key Findings & Data:We aimed to characterize genotype 4 infections in Kayseri by analyzing the demographic and laboratory data of 218 HCV RNA-positive, treatment-naive patients admitted to the Kayseri Training and Research Hospital in 2010 and 2011.
💡
Conclusion & Impact:Conclusion: The introduction of type 4d HCV into the Kayseri region probably took place 30-75 years ago, as predicted by molecular clock analysis.
🔬Design:Research Article
📍Scope:2010 Verileri
⚙️Variables:Hepatitis C virus · genotype 4d · phylogenetic analysis

Abstract

Background/aim: The frequency of genotype 4 hepatitis C virus (HCV) infections is significantly higher in Kayseri compared to other provinces in Turkey. We aimed to characterize genotype 4 infections in Kayseri by analyzing the demographic and laboratory data of 218 HCV RNA-positive, treatment-naive patients admitted to the Kayseri Training and Research Hospital in 2010 and 2011. Materials and methods: The distributions of sex, age, and viral loads of these patients with respect to HCV genotypes were analyzed. We also characterized the type 4 sequences at the subtype level. Randomly selected sera from 32 of the 72 genotype 4 patients from this cohort were subjected to PCR amplification in the NS5B region and further characterized by sequencing and phylogenetic and molecular clock analysis. Results: Distribution rates of HCV genotypes 1, 4, and 2 in the 218 patients were 62.4%, 33.0%, and 4.6%, respectively. Most of the patients infected with types 1 and 4 were over the age of 40 and female. The NS5B sequences of 32 Kayseri genotype 4 isolates were closely related with type 4d sequences but formed a separate cluster. Conclusion: The introduction of type 4d HCV into the Kayseri region probably took place 30-75 years ago, as predicted by molecular clock analysis.

Özet

Background/aim: The frequency of genotype 4 hepatitis C virus (HCV) infections is significantly higher in Kayseri compared to other provinces in Turkey. We aimed to characterize genotype 4 infections in Kayseri by analyzing the demographic and laboratory data of 218 HCV RNA-positive, treatment-naive patients admitted to the Kayseri Training and Research Hospital in 2010 and 2011. Materials and methods: The distributions of sex, age, and viral loads of these patients with respect to HCV genotypes were analyzed. We also characterized the type 4 sequences at the subtype level. Randomly selected sera from 32 of the 72 genotype 4 patients from this cohort were subjected to PCR amplification in the NS5B region and further characterized by sequencing and phylogenetic and molecular clock analysis. Results: Distribution rates of HCV genotypes 1, 4, and 2 in the 218 patients were 62.4%, 33.0%, and 4.6%, respectively. Most of the patients infected with types 1 and 4 were over the age of 40 and female. The NS5B sequences of 32 Kayseri genotype 4 isolates were closely related with type 4d sequences but formed a separate cluster. Conclusion: The introduction of type 4d HCV into the Kayseri region probably took place 30-75 years ago, as predicted by molecular clock analysis.

🔖

Cite This Article

KAYMAN, T., POLAT, C., ERGÖR, G., ABACIOĞLU, Y. H. (2015). Characterization of HCV genotype 4d infections in Kayseri, Turkey*. Turkish Journal of Medical Sciences, Cilt: 45 - Sayı: 3, 547–552. https://ajindex.com/articles/113944

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Shinol RC, Gale HB, Kan VL. Performance of the Abbott RealTime HCV Genotype II RUO Assay. J Clin Microbiol 2012; 50: 3099–3101.
  2. Simmonds P, Bukh J, Combet C, Deléage G, Enomoto N, Feinstone S, Halfon P, Inchauspé G, Kuiken C, Maertens G et al. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 2005; 42: 962–973.
  3. Murphy D, Chamberland J, Dandavino R, Sablon E. A new genotype of hepatitis C virus originating from Central Africa. Hepatology 2007; 46: 623A. Bostan N, Mahmood T. An overview about hepatitis C: a devastating virus. Crit Rev Microbiol 2010; 36: 91–133.
  4. Kamal SM, Nasser IA. Hepatitis C virus genotype 4: what we know and what we don’t yet know. Hepatology 2008; 47: 1371– 1383. 6. Nguyen MH, Keeffe EB. Prevalence and treatment of hepatitis C virus genotypes 4, 5, and 6. Clin Gastroenterol Hepatol 2005; 3(10 Suppl. 2): 97–101.
  5. Antaki N, Craxi A, Kamal S, Moucari R, Van der Merwe S, Haffar S, Gadano A, Zein N, Lai CL, Pawlotsky JM et al. The neglected hepatitis C virus genotypes 4, 5 and 6: an international consensus report. Liver Int 2010; 30: 342–355. 8. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of hepatitis C virus infection. J Hepatol 2011; 55: 245–264.
  6. Kuiken C, Simmonds P. Nomenclature and numbering of hepatitis C virus. In: Hengli T, editor. Hepatitis C: Methods and Protocols. 2nd ed. Tallahassee, FL, USA: Florida State University; 2009. pp. 33–53. Lavanchy D. Evolving epidemiology of hepatitis C virus. Clin Microbiol Infect 2011; 17: 107–115.
  7. Abacioglu YH, Davidson F, Tuncer S, Yap PL, Ustacelebi S, Yulug N, Simmonds P. The distribution of hepatitis C virus genotypes in Turkish patients. J Viral Hepat 1995; 2: 297–301.
  8. Kayman T, Karakükçü Ç, Karaman A, Gözütok F. Genotypic distribution of hepatitis C virus infection in Kayseri region. J Turk Microbiol Soc 2012; 42: 21–26 (in Turkish with English abstract). Gökahmetoğlu S, Atalay MA, Kılınç A. Determination of the hepatitis C virus genotypes with pyrosequencing method. Erciyes Med J 2011; 33: 99–102 (in Turkish with English abstract). Laperche S, Lunel F, Izopet J, Alain S, Dény P, Duverlie G, Gaudy C, Pawlotsky JM, Plantier JC, Pozzetto B et al. Comparison of hepatitis C virus NS5b and 5’ noncoding gene sequencing methods in a multicenter study. J Clin Microbiol 2005; 43: 733–739.
  9. Kuiken C, Yusim K, Boykin L, Richardson R. The Los Alamos hepatitis C sequence database. Bioinformatics 2005; 21: 3